1. Home
  2. SVC vs ALLO Comparison

SVC vs ALLO Comparison

Compare SVC & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVC
  • ALLO
  • Stock Information
  • Founded
  • SVC 1995
  • ALLO 2017
  • Country
  • SVC United States
  • ALLO United States
  • Employees
  • SVC N/A
  • ALLO N/A
  • Industry
  • SVC Real Estate Investment Trusts
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SVC Real Estate
  • ALLO Health Care
  • Exchange
  • SVC Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • SVC 453.3M
  • ALLO 427.7M
  • IPO Year
  • SVC N/A
  • ALLO 2018
  • Fundamental
  • Price
  • SVC $2.63
  • ALLO $2.05
  • Analyst Decision
  • SVC Buy
  • ALLO Strong Buy
  • Analyst Count
  • SVC 2
  • ALLO 9
  • Target Price
  • SVC $5.25
  • ALLO $10.29
  • AVG Volume (30 Days)
  • SVC 2.1M
  • ALLO 10.4M
  • Earning Date
  • SVC 02-26-2025
  • ALLO 03-13-2025
  • Dividend Yield
  • SVC 1.64%
  • ALLO N/A
  • EPS Growth
  • SVC N/A
  • ALLO N/A
  • EPS
  • SVC N/A
  • ALLO N/A
  • Revenue
  • SVC $1,896,928,000.00
  • ALLO $43,000.00
  • Revenue This Year
  • SVC N/A
  • ALLO N/A
  • Revenue Next Year
  • SVC N/A
  • ALLO N/A
  • P/E Ratio
  • SVC N/A
  • ALLO N/A
  • Revenue Growth
  • SVC 1.23
  • ALLO 26.47
  • 52 Week Low
  • SVC $2.29
  • ALLO $1.32
  • 52 Week High
  • SVC $6.85
  • ALLO $5.15
  • Technical
  • Relative Strength Index (RSI)
  • SVC 39.54
  • ALLO 51.61
  • Support Level
  • SVC $2.81
  • ALLO $1.69
  • Resistance Level
  • SVC $3.00
  • ALLO $2.32
  • Average True Range (ATR)
  • SVC 0.18
  • ALLO 0.22
  • MACD
  • SVC -0.04
  • ALLO 0.00
  • Stochastic Oscillator
  • SVC 19.86
  • ALLO 35.79

About SVC Service Properties Trust

Service Properties Trust is a real estate investment trust that owns hotel properties. These properties are located in the United States, along with Canada and Puerto Rico. The company operates through its hotel investment unit and net lease investments. The firm derives the majority of its revenue from the hotel real estate investments unit. The hotels are distinguished between their service levels, which include full service, select service, and extended stay; and chain scale, which includes luxury, upper upscale, upscale, upper midscale, and midscale. The hotels are extended stay or upscale. Some of the hotel brands include Courtyard by Marriott, Royal Sonesta, Crowne Plaza Hotels & Resorts, and Hyatt Place.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: